DK0539492T3 - Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner - Google Patents

Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner

Info

Publication number
DK0539492T3
DK0539492T3 DK91913698T DK91913698T DK0539492T3 DK 0539492 T3 DK0539492 T3 DK 0539492T3 DK 91913698 T DK91913698 T DK 91913698T DK 91913698 T DK91913698 T DK 91913698T DK 0539492 T3 DK0539492 T3 DK 0539492T3
Authority
DK
Denmark
Prior art keywords
antigenic
meningitidis
akin
toxins
iron
Prior art date
Application number
DK91913698T
Other languages
Danish (da)
English (en)
Inventor
Frederick Sparling P
Alan Thompson Stuart
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of DK0539492T3 publication Critical patent/DK0539492T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91913698T 1990-07-16 1991-07-16 Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner DK0539492T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55264990A 1990-07-16 1990-07-16
PCT/US1991/005014 WO1992001460A1 (en) 1990-07-16 1991-07-16 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins

Publications (1)

Publication Number Publication Date
DK0539492T3 true DK0539492T3 (da) 2003-09-22

Family

ID=24206214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913698T DK0539492T3 (da) 1990-07-16 1991-07-16 Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner

Country Status (9)

Country Link
EP (2) EP1338607A3 (ja)
JP (2) JP3329452B2 (ja)
AT (1) ATE242784T1 (ja)
AU (1) AU8298991A (ja)
CA (1) CA2087160A1 (ja)
DE (1) DE69133276T2 (ja)
DK (1) DK0539492T3 (ja)
ES (1) ES2202297T3 (ja)
WO (1) WO1992001460A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
ATE527360T1 (de) * 1998-12-08 2011-10-15 Glaxosmithkline Biolog Sa Neue verbindungen abgeleitet von neisseria meningitidis
CA2359492A1 (en) 1999-01-15 2000-07-20 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
JP2006500963A (ja) 2002-08-02 2006-01-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
WO2004039417A2 (en) 2002-11-01 2004-05-13 Glaxosmithkline Biologicals S.A. Drying process
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
ATE450271T1 (de) 2006-06-12 2009-12-15 Glaxosmithkline Biolog Sa Impfstoff
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine

Also Published As

Publication number Publication date
JPH06502394A (ja) 1994-03-17
CA2087160A1 (en) 1992-01-17
EP1338607A3 (en) 2004-08-18
EP1338607A2 (en) 2003-08-27
AU8298991A (en) 1992-02-18
EP0539492A1 (en) 1993-05-05
EP0539492A4 (en) 1993-09-01
JP2002233390A (ja) 2002-08-20
ATE242784T1 (de) 2003-06-15
DE69133276D1 (de) 2003-07-17
EP0539492B1 (en) 2003-06-11
ES2202297T3 (es) 2004-04-01
WO1992001460A1 (en) 1992-02-06
DE69133276T2 (de) 2003-11-27
JP3329452B2 (ja) 2002-09-30

Similar Documents

Publication Publication Date Title
DK0539492T3 (da) Antigene jernundertrykkelige proteiner fra N. meningitidis beslægtet med hemolysinfamilien af toksiner
DE69534872D1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
TW279178B (ja)
DE69737125D1 (de) Streptococcus pneumoniae antigene und impfstoffe
NO940502D0 (no) Fremgangsmåter og blandinger i forbindelse med anvendelige antigener av Moraxella Catarrhalis
ATE524194T1 (de) Antigene polypeptide
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
DK0498851T3 (da) Tumorassocieret urinantigen, anvendelse af antigene underenheder og fremgangsmåder til detektion
ZA895867B (en) Infectious bursal disease virus
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
ATE111606T1 (de) Ein gattungsspezifisches listeria-antigen, identifiziert durch monoklonale antikörper.
ZA872711B (en) Affinity chromatography material and its use in the separation and purification of protein antigens of the bacteria of the bordetella genus
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
ATE266090T1 (de) Gegen mumps impfstoff, das ein virus des jeryl- lynn stammes enthält
ZA200006489B (en) Moraxella catarrhalis proteins.
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens